By [ad_1]
Battle Royale: ‘No Time to Die’ is Outpacing ‘Venom 2’ in Pre-Sales
After an 18-month release date delay due to the pandemic, the anticipation for MGM/EON/United Artist Releasing’s 25th James Bond movie, No Time to Die, is no doubt huge: Fandango is reporting that the advance ticket sales for Daniel Craig’s swan song as 007 are already outstripping Universal’s F9 and Sony’s Venom: Let There Be Carnage, and it’s on target to become the online ticket seller’s best ever for a Bond movie.
Fandango reports that already hundreds of showtimes are sold out across the U.S. with theater owners adding new showtimes to meet fan demand.
No Time to Die is the first Bond movie to be shot in Imax 15/70MM cameras with 40 minutes of expanded ratio in the large format exhibitor’s auditoriums. It’s the first 007 title to be shown in RealD, 3D, Dbox, 4DX, and ScreenX. No Time to Die gets all the PLF and Imax screens over the next two weeks before Warner Bros./Legendary’s Dune opens.
While industry projections for No Time to Die‘s opening weekend are conservative in the $55M-$60M+ range, many are waiting at the edge of their seat for an overperformance here. There’s just been too much anticipation. Sony’s Venom: Let There Be Carnage on a very long theatrical window that’s well above 45 days, posted a pandemic record of $90M this past weekend. Other big openings during Covid include Black Widow ($80.3M), Shang-Chi and the Legend of the Ten Rings ($75M) and F9 ($70M). Already, via Universal, No Time to Die has racked up over $121M in its offshore debut.
via Deadline
[ad_2]
